FertiCult™ IVF Medium FertiPro
Soluzione equilibrata per coltura embrionale a breve termine, pronta all’uso
CARATTERISTICHE
- Uso per coltura fino a 48 ore
- Contiene HSA al 0,4%
FertiCult™ IVF Medium FertiPro
SpecificazioniFertiCult ™ IVF Medium FertiPro
FertiCult ™ IVF Medium è una soluzione salina chimicamente equilibrata con 0,4% HSA per la coltura in vitro di embrioni di mammiferi. È progettato solo per la cultura a breve termine (fino a 48 ore in cultura). Il terreno è pronto all’uso e non richiede ulteriori additivi.
Validità prodotto 12 mesi da data produzione.
Prodotto Marcato CE
Bibliografia
Benchaib M., Braun V., Ressnikof D., Lornage J., Durand P., Niveleau A., Guerin J.F., Influence of global sperm DNA methylation on IVF results, Human Reproduction (2005),Vol.20,No.3,pp.768-773
Chen N., Liow S-L., Yip W-Y., Tan L-G., Tong G-Q., NG S-C., Dynamic Changes in Microtubules and Early Development of Reconstructed Embryos after Somatic Cell Nuclear Transfer in a Non-Human Primate, Cloning and Stem Cells (2006),Vol.8,No.4,pp.251-258
Dadoune J.P., Pawlak A., Alfonsi M.F., Siffroi J.P., Identification of transcripts by macroarrays, RT�PCR and in situ hybridization in human ejaculate spermatozoa, Molecular Human Reproduction (2005),Vol.11,No.2,pp.133-140
Gruber I., Klein M., Embryo culture media for human IVF: which possibilities exist?, J Turkish-German Gynecol Assoc (2011),Vol.12,pp.110-7
How to demonstrate that eSET does not compromise the likelihood of having a baby?, Bechoua S., Astruc K., Thouvenot S., Girod S., Chiron A., Jimenez C., Sagot P., Human Reproduction (2009),Vol.24,No.12,pp.3073-3081
Ng S-C., Chen N., Yip W-Y., Liow S-L., Tong G-Q., Martelli B., Tan L.G., Martellli P., The first cell cycle after transfer of somatic cell nuclei in a non-human primate, Development and Disease (2004),Vol.131,No.10,pp.2475-2484
Perraguin-Jayot S., Audebert A., Emperaire J.C., Parneix I., Ongoing pregnancies after intracytoplasmic injection using cryopreserved testicular spermatozoa, Human Reproduction (1997),Vol.12,No.12,pp.2706-2709
Uhrin P., Dewerchin M., Hilpert M., Chrenek P., Schöfer C., Zechmeister-Machhart M., Krönke G., Vales A., Carmeliet P., Binder B.R., Geiger M., Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility, The Journal of Clinical Investigation (2000),Vol.106,No.12,pp.1531-1539
Wolff J-P., Day 3 compared to day 2 cryopreservation does not affect embryo survival but improves the outcome of frozen-thawed embryo transfers, Fertility and Sterility (2006),Vol.86,No.5,pp.1537-40
Zairi A., Bela�d A., Gahbiche A., Hani K., Spermicidal activity of dermaseptins, Contraception (2005),Vol.72,pp.447-453
Ziyyat A., Naud-Barriant N., Barraud-Lange V., Chevalier F., Kulksi O., Lemkecher T., Bomsel M., Wolf J.P., Cyclic FEE peptide increases human gamete fusion and potentiates its RGD-induced inhibition, Human Reproduction (2005),Vol.20,No.12,pp.3452-3458
Ziyyat A., Rubinstein E., Monier-Gavelle F., Barraud V., Kulski O., Prenant M., Boucheix C., Bomsel M., Wolf J-P., CD9 controls the formation of clusters that contain tetraspanins and the integrin alpha6beta1, which are involved in human and mouse gamete fusion, Journal of Cell Science (2006),Vol.119,pp.416-424
- Scheda tecnica